PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

April 21, 2026

mental-health

PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

ONLY AVAILABLE IN PAID PLANS.

Originally reported by biospace. Read more

Source: https://www.biospace.com/press-releases/pharmather-highlights-strategic-ketamine-opportunity-following-new-u-s-executive-order-on-psychedelic-treatments-for-serious-mental-illness